The Big 3: LULU, LLY & SMCI

[@blakeaaron5698]

LULU is losing a lot of market share, especially for men (Vuori), BUT still has a strong customer base.
LLY is not the only drug maker for weight-loss pokes, and it's overbought.
SMCI will eventually drop much lower, but it won't be straight down.

[@johnc3473]

Nope, smci will move up

[@johnrivera6951]

trailer

[@owl4638]

☠️

[@Sofie8211]

Lly to 1005 and smci to 1200 yes please